summary
Introduced
01/23/2026
01/23/2026
In Committee
01/23/2026
01/23/2026
Crossed Over
Passed
Dead
Introduced Session
194th General Court
Bill Summary
Relative to epinephrine injectors
AI Summary
This bill mandates that various health insurance plans and programs in Massachusetts must cover the appropriate weight-based dosage of epinephrine injectors, which are devices approved by the U.S. Food and Drug Administration (FDA) for administering epinephrine, including auto-injectors and pre-filled syringes with pre-measured doses equivalent to auto-injectors. This coverage requirement applies to state employees insured through the Group Insurance Commission, individuals covered by Medicaid-managed care or primary care clinician plans, and those with various types of private insurance policies, including accident and sickness insurance, employers' health and welfare funds, hospital service plans, medical service agreements, and health maintenance contracts. Importantly, these epinephrine injectors cannot be subjected to higher deductibles, coinsurance, copayments, or out-of-pocket limits than other prescribed drugs covered by the respective plans.
Committee Categories
Health and Social Services
Sponsors (0)
No sponsors listed
Other Sponsors (1)
Joint Committee on Financial Services (Joint)
Last Action
Reported favorably by committee and referred to the Joint Committee on Health Care Financing (on 01/23/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/194/H4943 |
| BillText | https://malegislature.gov/Bills/194/H4943.pdf |
Loading...